Home > Drugs A-Z > Senna and Docusate Sodium

Senna and Docusate Sodium (Sunrise Pharmaceutical Inc)

Available Formats

Dosage Form Package Information Links
TABLET, FILM COATED 60 TABLET, FILM COATED in 1 BOTTLE (11534-134-60) Label Information
TABLET, FILM COATED 57603 TABLET, FILM COATED in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK (11534-134-05) Label Information

Complete Senna and Docusate Sodium Information

  • OTC - ACTIVE INGREDIENT

    Docusate sodium 50 mg, Sennoside 8.6 mg.


  • OTC - PURPOSE

    Stimulant laxative.


  • INDICATIONS AND USAGE

    For temporary relief of occasional constipation and irregularity.

    This product generally produces bowel movement in 6 to 12 hours.


  • WARNINGS

    Do not use:

    laxative products for longer than 1 week unless told to do so by a doctor.

    if you are presently taking mineral oil, unless told to do so by a doctor


  • OTC - ASK DOCTOR

    Before use if you have:

    Stomach pain, nausea or vomiting

    Noticed a sudden change in bowel habits that lasts over 2 weeks.


  • OTC - STOP USE

    If you have rectal bleeding or fail to have bowel movement after use of a laxative. This could be a serious condition.


  • OTC - PREGNANCY OR BREAST FEEDING

    Ask a health professional before use.


  • OTC - KEEP OUT OF REACH OF CHILDREN

    In case of overdose, get medical help or contact a Poison Control Center right away.


  • DOSAGE AND ADMINISTRATION

    Drink with a full glass of water with each dose

    Adults and children 12 years and over take 2 - 4 tablets daily
    Children 6 to under 12 years take 1 - 2 tablets daily
    Children 2 to under 6 years take up to 1 tablet daily
    Children under 2 years of age Ask a doctor

    OTHER INFORMATION

    Each tablet contains: calcium 30 mg, sodium 3 mg VERY LOW SODIUM.

    Do not use if the imprinted safety seal under cap is missing or damaged.

    Store at at 25°C (77°F); excursions permitted between 15(-30(C (59(-86(F)

    Keep tightly closed.


  • INACTIVE INGREDIENT

    Colloidal silicon dioxide, dicalcium phosphate, ethanol, FD&C blue #2, FD&C red #40, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, pregelatinized starch, silicon dioxide, sodium benzoate, stearic acid, titanium dioxide.


  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    d08a4708-figure-01

  • INGREDIENTS AND APPEARANCE
    SENNA AND DOCUSATE SODIUM 
    senna and docusate sodium tablet, film coated
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:11534-134
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM 50 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg
    Inactive Ingredients
    Ingredient Name Strength
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    ALCOHOL (UNII: 3K9958V90M)  
    FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    HYPROMELLOSE 2208 (100 MPA.S) (UNII: B1QE5P712K)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    Color RED Score no score
    Shape ROUND Size 10mm
    Flavor Imprint Code S134
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:11534-134-60 60 in 1 BOTTLE
    2 NDC:11534-134-05 57603 in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC monograph not final part334 07/26/2007
    Labeler - Sunrise Pharmaceutical Inc (168522378)